This website is intended for healthcare professionals

PREVIEW: Modern Thinking in MS Management – Educational Meeting for Specialist Multiple Sclerosis Nurses, organised and funded by Teva UK Ltd

Posted in Courses & Conferences on 31st Jan 2013

Course details: Friday 10th (evening) and Saturday 11th May 2013 Venue: Radisson Blu Portman Hotel, Portman Square, London W1, UK.

Teva UK Ltd would like to invite practising specialist Multiple Sclerosis nurses to the second ‘Modern Thinking in MS Management’ national educational meeting. This meeting aims to bring together around 100 nurses from across the UK providing a platform for discussion and review of the current and future management of MS.

With well established and emerging therapeutic options for MS treatment, this forum will allow delegates the opportunity to interact with a faculty of high calibre specialists. Throughout the day, delegates will be invited to review strategies through lively debate and informative discussion and to take part in interactive workshop sessions.

Event highlights include

  • Developments and trends in MS diagnosis and management
  • Presentation of ongoing research
  • Interactive workshops and debates
  • Hot topic sessions

To register your interest for this meeting: Please email your name, job title, institutional affiliation and postal address to modernthinking@apothecom.com. There is no registration fee for the meeting.

Please note that places for the meeting are limited and you will be contacted in due course if you have a place to confirm at the meeting. We do hope that you are able to join us for this important review of current treatment and a look at the future of MS management. The second ‘Modern Thinking in MS management’ meeting promises to be an exciting, stimulating and informative event. CME accreditation is being sought. Your personal details will only be used for the purposes of this meeting.

Teva UK Limited or ApotheCom will not sell, share, or otherwise distribute your personal data to third parties outside Teva. CPX/12/0003a – Date of preparation: November 2012